Pictet Asset Management Holding SA »

Neurocrine Biosciences shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-09-30 $97M 842k 115.21
2024-03-31 $149M 1.1M 137.91

More positions owned by Pictet Asset Management Holding SA

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Thermo Fisher Scientific (TMO)
Amazon (AMZN)
Republic Services (RSG)
Meta Platforms Cl A (META)
salesforce (CRM)
Waste Connections (WCN)
Equinix (EQIX)
Ecolab (ECL)
Ubs Group SHS (UBS)
Kla Corp Com New (KLAC)
Broadcom (AVGO)

View all positions for Pictet Asset Management Holding SA

Top funds holding Neurocrine Biosciences

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Bellevue Group
Geode Capital Management
Citadel Advisors
AQR Capital Management
T. Rowe Price Associates
Morgan Stanley
Jpmorgan Chase & Co
Deerfield Management Company
Dodge & Cox
Goldman Sachs Group

View all funds holding Neurocrine Biosciences